FI900412A0 - Antiviral eller antibakteriell foerening och foerfarande foer anvaendning daerav. - Google Patents

Antiviral eller antibakteriell foerening och foerfarande foer anvaendning daerav.

Info

Publication number
FI900412A0
FI900412A0 FI900412A FI900412A FI900412A0 FI 900412 A0 FI900412 A0 FI 900412A0 FI 900412 A FI900412 A FI 900412A FI 900412 A FI900412 A FI 900412A FI 900412 A0 FI900412 A0 FI 900412A0
Authority
FI
Finland
Prior art keywords
antiviral
antibakteriell
foerening
eller
foerfarande foer
Prior art date
Application number
FI900412A
Other languages
English (en)
Finnish (fi)
Inventor
Witold Kiczka
Original Assignee
Nika Health Care Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Care Inc filed Critical Nika Health Care Inc
Publication of FI900412A0 publication Critical patent/FI900412A0/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI900412A 1988-05-26 1990-01-25 Antiviral eller antibakteriell foerening och foerfarande foer anvaendning daerav. FI900412A0 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17858888A 1988-05-26 1988-05-26
PCT/US1988/001785 WO1989011294A1 (en) 1988-05-26 1988-05-26 Antiviral or antibacterial compound and method of use
OA59731A OA09785A (en) 1988-05-26 1990-01-26 Antiviral or antibacterial compound and method of use

Publications (1)

Publication Number Publication Date
FI900412A0 true FI900412A0 (fi) 1990-01-25

Family

ID=33162813

Family Applications (1)

Application Number Title Priority Date Filing Date
FI900412A FI900412A0 (fi) 1988-05-26 1990-01-25 Antiviral eller antibakteriell foerening och foerfarande foer anvaendning daerav.

Country Status (23)

Country Link
US (3) US5200182A (da)
EP (1) EP0380484B1 (da)
JP (1) JPH0649659B2 (da)
AT (1) ATE93143T1 (da)
AU (1) AU624331B2 (da)
BG (1) BG60544B1 (da)
CA (1) CA1335425C (da)
CS (1) CS277030B6 (da)
DK (1) DK173078B1 (da)
ES (1) ES2011577A6 (da)
FI (1) FI900412A0 (da)
HK (1) HK42394A (da)
HU (1) HU204710B (da)
IL (1) IL90092A (da)
LV (1) LV10054B (da)
MA (1) MA21560A1 (da)
MW (1) MW390A1 (da)
OA (1) OA09785A (da)
PH (1) PH26284A (da)
RU (1) RU2092183C1 (da)
WO (1) WO1989011294A1 (da)
YU (1) YU109289A (da)
ZA (1) ZA893382B (da)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0380484B1 (en) * 1988-05-26 1993-08-18 Nika Health Products Limited Use of a lysozyme dimer and/or a ribonuclease dimer for th emanufacture of an antiviral or antibiotic drug
US5989880A (en) 1990-01-08 1999-11-23 Nika Health Products Ltd. Method of preparing lysozyme dimers
RU2067617C1 (ru) * 1990-01-08 1996-10-10 Ника Хелт Продактс Лтд. Способ получения димера лизоцима
PL173978B1 (pl) * 1992-07-13 1998-05-29 Nika Health Products Ltd Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
CH682541A5 (de) * 1992-06-23 1993-10-15 Urs Viktor Dr Wirth Biochemische Inaktivierung von RNA-Viren.
US6183742B1 (en) 1992-07-13 2001-02-06 Nika Health Products, Limited Applications of lysozyme dimer
DZ1964A1 (fr) * 1995-01-13 2002-10-15 Nika Health Products Ltd Nouvelle applications d'un dimère de lysozyme.
GB2304048A (en) * 1995-08-12 1997-03-12 John William Carson Medicament containing saliva extract
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
US6716813B2 (en) * 2000-11-28 2004-04-06 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
US7338936B2 (en) * 2000-11-28 2008-03-04 House Ear Institute Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis
JP2002187853A (ja) * 2000-12-21 2002-07-05 Shinei Ferumentekku:Kk 動物の乳頭除菌剤および菌環境改善方法
DE10210285A1 (de) * 2002-03-08 2003-11-13 Medigene Ag Reversibles Toxin und seine Verwendung
JP2008505853A (ja) * 2004-04-13 2008-02-28 クインテセンス バイオサイエンシーズ インコーポレーティッド 細胞傷害性薬剤としての非天然のリボヌクレアーゼ複合体
US20050244402A1 (en) * 2004-04-30 2005-11-03 Villanueva Julie M Absorption of pain-causing agents
US7348301B2 (en) * 2006-02-16 2008-03-25 Buckman Laboratories International, Inc. Lysozyme-based method and composition to control the growth of microorganisms in aqueous systems
WO2007149594A2 (en) * 2006-06-23 2007-12-27 Quintessence Biosciences, Inc. Modified ribonucleases
EP2049151A4 (en) 2006-07-17 2010-03-24 Quintessence Biosciences Inc METHOD AND COMPOSITIONS FOR THE TREATMENT OF CANCER
RU2009136424A (ru) * 2007-03-02 2011-04-10 СЕНТ СИМЕОН ЭлДиЭй (US) Композиция и способ лечения папилломавируса и саркоидов лошадей
WO2009036000A2 (en) * 2007-09-11 2009-03-19 University Of Maryland, Baltimore Methods of treating a microbial infection by modulating rnase-l expression and/or activity
US8697062B2 (en) * 2007-10-08 2014-04-15 Quintessence Biosciences, Inc. Compositions and methods for ribonuclease-based therapeutics
EP2334695B1 (en) 2008-10-01 2015-12-23 Quintessence Biosciences, Inc. Therapeutic ribonucleases
US20100215707A1 (en) * 2009-02-25 2010-08-26 Mcdonald Thomas Activated creatinine and precursors thereof as antibacterial agents, compositions and products containing such agents and uses thereof
NZ600269A (en) 2009-05-20 2014-02-28 Dec Int Nz Ltd Delivery device for treatment of mastitis
PL2457576T3 (pl) 2010-11-29 2021-04-06 Eurochit Danuta Kruszewska Szczep Lactobacillus reuteri do stosowania medycznego i weterynaryjnego w profilaktyce oraz w leczeniu zespołu metabolicznego lub infekcji
RU2548803C2 (ru) * 2011-11-28 2015-04-20 Общество с ограниченной ответственностью " Фарматренд" ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ ДЛЯ ЛЕЧЕНИЯ ГЛАЗНЫХ ИНФЕКЦИЙ P. Aeruginosa, СОДЕРЖАЩАЯ РЕКОМБИНАНТНЫЙ ЛИЗОЦИМ
RU2509801C2 (ru) * 2012-03-22 2014-03-20 Борис Михайлович Куриненко СПОСОБ ИСПОЛЬЗОВАНИЯ РИБОНУКЛЕАЗЫ Bacillus intermedius
EA201491272A1 (ru) 2012-05-29 2015-10-30 Данута Кружевска Нанопродукт, содержащий lactobacillus reuteri dan080, подходящий для профилактики и терапии - человеческой и ветеринарной, и его медицинское применение
EP2674162A1 (en) 2012-05-29 2013-12-18 Danuta Kruszewska Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same
RU2504397C1 (ru) * 2012-10-25 2014-01-20 Леонид Леонидович Клопотенко Фармацевтическая композиция, содержащая фермент рибонуклеазу и глицирризиновую кислоту или ее соли: глицирризинат аммония, или дикалия, или тринатрия
US9950075B2 (en) 2013-03-15 2018-04-24 The University Of Massachusetts Compositions and methods for delivering agents to the central nervous system
US9573980B2 (en) 2013-03-15 2017-02-21 Spogen Biotech Inc. Fusion proteins and methods for stimulating plant growth, protecting plants from pathogens, and immobilizing Bacillus spores on plant roots
WO2015125961A1 (ja) 2014-02-21 2015-08-27 国立大学法人東京海洋大学 ノロウィルス不活化剤及びその製造方法、ノロウィルス不活化方法、ノロウィルス不活化用リゾチーム類の製造方法、ノロウィルス感染の予防薬又は治療薬、並びにノロウィルス不活化用皮膚外用剤
CN106659165B (zh) * 2014-07-31 2021-06-01 丘比株式会社 含水流动状组合物及其制造方法、以及溶菌酶加工品和/或其盐、及其制造方法
BR122023020809A2 (pt) 2014-09-17 2024-01-23 Spogen Biotech Inc. Proteína de fusão
LV15071B (lv) * 2015-07-14 2016-02-20 Rīgas Stradiņa Universitāte Kompozīcija subklīniska mastīta ārstēšanai govīm
RU2634264C1 (ru) * 2016-09-19 2017-10-24 Александр Ливиевич Ураков Крем-молочко для лечения опоясывающего лишая
KR102470362B1 (ko) 2016-12-28 2022-11-25 디아이씨 가부시끼가이샤 분산체 및 그것을 사용한 잉크젯용 잉크 조성물, 광변환층, 및 액정 표시 소자
BR112020005730A2 (pt) 2017-09-20 2020-10-20 Spogen Biotech Inc. proteínas de fusão, membro da família bacillus cereus, fragmentos de exosporium, formulação, semente de planta e métodos para estimular o crescimento de plantas e para entregar uma enzima
EP4003300A4 (en) * 2019-07-26 2023-06-28 Infinant Health, Inc Nutritive compositions with bioactive proteins

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1268M (fr) * 1961-06-29 1962-04-24 Puiseux Médicament antimitotique et antiviral.
FR4020M (da) * 1965-01-29 1966-03-21
DE1517751C3 (de) * 1965-07-08 1975-02-27 Eisai Co., Ltd., Tokio Verfahren zum Verhindern der Bildung von flockigen Lysozym- und/oder Lysozymsalzniederschlägen in wässrigen Lösungen, die Lysozym und/oder Lysozymsalze enthalten
DE1545644A1 (de) * 1965-12-06 1969-08-07 Boehringer Sohn Ingelheim Verfahren zur Herstellung von neuen quaternaeren Scopolammoniumsalzen
GB1110504A (en) * 1966-03-18 1968-04-18 Prodotti Antibiotici Spa Pharmaceutical compositions
US4221794A (en) * 1979-06-21 1980-09-09 Newport Pharmaceuticals International, Inc. Method of imparting immunomodulating and antiviral activity
US4510144A (en) * 1981-08-26 1985-04-09 Newport Pharmaceuticals International Methods of imparting immunomodulating activity with dihydrothiazolo purine derivatives
CA1263378A (en) * 1985-01-08 1989-11-28 Robert James Alaimo Imidazo¬4,5-f|quinolines useful as immunomodulating agents
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
US4744984A (en) * 1985-10-08 1988-05-17 Vetrepharm Research, Inc. Antiviral immunotherapeutic agent and preparation thereof
EP0380484B1 (en) * 1988-05-26 1993-08-18 Nika Health Products Limited Use of a lysozyme dimer and/or a ribonuclease dimer for th emanufacture of an antiviral or antibiotic drug

Also Published As

Publication number Publication date
HK42394A (en) 1994-05-13
DK16890A (da) 1990-01-22
MW390A1 (en) 1990-11-14
CS277030B6 (en) 1992-11-18
JPH03504121A (ja) 1991-09-12
US5466449A (en) 1995-11-14
ATE93143T1 (de) 1993-09-15
PH26284A (en) 1992-04-10
HUT54060A (en) 1991-01-28
HU883981D0 (en) 1990-12-28
US5200182A (en) 1993-04-06
ZA893382B (en) 1991-01-30
LV10054A (lv) 1994-05-10
HU204710B (en) 1992-02-28
MA21560A1 (fr) 1989-12-31
IL90092A (en) 1995-03-30
RU2092183C1 (ru) 1997-10-10
BG60544B1 (en) 1995-08-28
YU109289A (en) 1991-08-31
AU1940888A (en) 1989-12-12
OA09785A (en) 1994-04-15
DK173078B1 (da) 1999-12-20
AU624331B2 (en) 1992-06-11
EP0380484B1 (en) 1993-08-18
EP0380484A1 (en) 1990-08-08
JPH0649659B2 (ja) 1994-06-29
DK16890D0 (da) 1990-01-22
CA1335425C (en) 1995-05-02
ES2011577A6 (es) 1990-01-16
WO1989011294A1 (en) 1989-11-30
LV10054B (en) 1995-02-20
BG91270A (bg) 1993-12-24
US6099835A (en) 2000-08-08
CS318089A3 (en) 1992-05-13

Similar Documents

Publication Publication Date Title
FI900412A0 (fi) Antiviral eller antibakteriell foerening och foerfarande foer anvaendning daerav.
PT90465A (pt) Processo de preparacao de derivados da guanina imuno-estimulantes e de composicoes farmaceuticas que os contem
YU47543B (sh) Postupak za dobijanje farmaceutskog preparata za stimulaciju granulocita
CA2068324A1 (en) Metal-peptide compositions and methods for stimulating hair growth
PT911033E (pt) Utilizacao do interferao de consenso para a reducao dos efeitos secundarios do tratamento com interferoes na hepatite viral
PT90464A (pt) Processo de preparacao de derivados da guanina imuno-estimulantes e de composicoes farmaceuticas que os contem
KR950700333A (ko) 개량된 알파 인터페론 조성물 및 인간 말초혈 백혈구로부터의 제조 방법(improved alpha interferon composition and method for its production from human peripheral blood leukocytes)
FR2567885B1 (fr) Derives 3-aminopropoxyaryliques, leur preparation, leur application comme medicaments et compositions pharmaceutiques les contenant
IT1232827B (it) Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle
DK0531413T3 (da) Et antiviralt præparat indeholdende prostratin
NO893135L (no) Fremgangsmaate for fremstilling av n-2,3-butadienyl tri- og tetraaminoalkanderivater.
AU3329293A (en) Method of imparting antimicrobial activity to an ophthalmic composition
ES2098455T3 (es) Compuestos de ciclohexapeptidil propanolamina.
ES2016464A6 (es) Procedimiento para preparar derivados de 2', 5' -oligoadenilato.
MY106984A (en) Antiviral or antibacterial composition and method of use.
GR1001006B (el) Μεθοδος παρασκευης και χρησιμοποιησεως αντιιικων η αντιβακτηριακων συνθεσεων.
PT86933A (pt) Process for the preparation pf optically active oxo-isoindolinyul derivatives and of pharmaceutical compositions containing the same
NO158186C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive cis-2-(1h-imidazolylmethyl)-3-difluorbenzyloxy-2,3-dihydrofluorbenzo(b)thiofener.
GEP19971029B (en) Antiviral or antibacterial compound and method of use thereof
IT8348383A0 (it) Enzima simile a pepsina da leucocito umano, procedimento per prepararlo, e composizione terapeutica che lo contiene come ingrediente attivo
MX9307639A (es) Metodo para tratar infecciones virales con terapia conjuntiva con compuestos similares al aciclovir y un analogo de nucleosido 2'-viril substituido.
BE888313A (fr) Derives d'acides benzamioethylphenoxycyclohexylacetiques, leur procede de preparation et leur application en therapeutique,
SE9003140D0 (sv) Method and composition for treatment of heart diseases
FR2559485B2 (fr) Derives de pyrrolo-quinoline, leur preparation et leur application en therapeutique
FR2609029B1 (fr) Derives 5-aminoethyles de l'oxazolidinone-2, leur procede de preparation et leur application en therapeutique

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: NIKA HEALTH PRODUCTS, LTD.